Trial Profile
Randomized Placebo-Controlled Study of Sildenafil For The Treatment of Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis: A Pilot Study
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2018
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Pulmonary fibrosis
- Focus Therapeutic Use
- 02 Mar 2018 Status changed from recruiting to withdrawn prior to enrolment as inclusion/exclusion criteria limited enrollment
- 27 Mar 2008 New trial record.